- About Us
- My Account
Views expressed are those of the authors and are subject to change. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional or institutional investors only.
The pandemic’s path remains the key to the economic outlook, and what we’ve learned about it since last quarter is concerning: Additional variants are possible (and potentially more transmissible and virulent), vaccine protection could wane over time, and a significant percentage of the population may remain unvaccinated. This new reality is reflected in reduced economic activity, the resurgence of growth stocks over value, and a return to record lows in long-maturity yields (Figure 1). On a more positive note, growth is still strong, economies are unlikely to go back into lockdown, and stimulus remains supportive. All of this leaves markets caught between two narratives: The pace of growth seems poised to slow, but the level of growth is likely to remain above par.
Against this backdrop, we continue to seek a pro-risk stance over the next 6 − 12 months, preferring equities to bonds. But relative to last quarter, our optimism is tempered somewhat by a slight downgrade to our macro and policy outlook — including the potential for modestly slower growth, a slight reduction in policy support, and inflation that’s more persistent than the market expects. Within equities, we prefer Europe, which we continue to believe is on the cusp of economic outperformance, and we have reduced our emerging market (EM) view to neutral given the high costs of COVID, high inflation, and political volatility. We remain moderately bearish on government bonds in Europe in particular, as yields seem too low given our macro forecast. Credit spreads are generally rich, but we find some value in bank loans and EM debt.
We have been advocating value-oriented exposure from a sector, market-cap, and regional perspective. However, given the slightly less favorable fundamental and policy backdrop, we think asset allocators should be more balanced between growth and value. We continue to think commodities are supported by our inflation outlook and we favor energy and industrial metals, which have historically been more sensitive to rising inflation than equities and can potentially help hedge against a rise in interest rates.
We are moderately bullish on European equities due to attractive valuations, the sharp increase in vaccinations, and high savings levels, which should allow for more robust spending if consumer confidence increases as we expect. We are also optimistic that Germany’s elections this fall could lead to a more supportive fiscal environment, and one that may influence the broader European stance. While Europe has evaded Delta’s wrath better than the US thanks to higher vaccination rates, we are wary of the variant’s unpredictability and the potential for further spread on the continent.
We’ve downgraded our view on EM equities to neutral as many countries are experiencing expanding fiscal deficits and high inflation, and central bank rate hikes could slow domestic economies. Pockets of value persist among commodity exporters and countries less dependent on tourism, but differentiation is key. We would be selective in China given potential weakness in the cycle and uncertainty related to the government’s regulatory push and deleveraging in the property industry (Figure 2). Within Asia, we are neutral on Japanese equities. We see tailwinds from cheap valuations and Prime Minister Suga’s resignation, which should auger well for the business-friendly Liberal Democratic Party. But we are concerned about China’s slowdown, which may feed through to the broader region.
We maintain a neutral view on the US. We think the US economy will slow some but stay strong, and consumers are in great shape. While policy support is slowly coming off, it remains highly supportive. Indeed, the Fed seems convinced that inflation expectations will remain anchored at low levels even as it keeps its foot on the stimulus pedal. Our view is that inflation will be more persistent than expected, given challenging supply shortages, rising wages, and a hot housing market, which tends to lead to sticky shelter inflation. Higher, more persistent inflation could unsettle equity markets, and valuations are expensive. Thus, we prefer a quality bias and a balance between growth and value.
We are bullish on commodities given the inflation dynamics discussed, as well as supply/demand imbalances across energy, metals, and agriculture. Capital expenditures have been very weak for the past decade following a free-spending period focused on growth rather than profitability. More structurally, environmental concerns are feeding into higher costs and potentially lower supply. Our research shows that commodities have historically been the only asset with a materially positive beta to inflation, so from a portfolio construction standpoint, we see a case for at least some commodities exposure.
We agree with market consensus that the Fed is likely to begin tapering around year end. We see the European Central Bank (ECB) as more hawkish relative to the nominal growth picture in its economy, and we think sovereign rates in Europe are likely to drift upward. In credit, valuations are rich, with most spreads well inside of median levels. However, defaults are likely to stay very low and demand technicals are strong as demographics and pensions generate huge demand for yield.
Within credit, we prefer EM debt to US high yield as EM spreads are considerably wider (Figure 3). Credit valuations have been a reliable indicator of forward excess returns, a dynamic we continue to trust. We think Mexico, Russia, and EM countries in Central and Eastern Europe are attractive. We also prefer bank loans, which offer attractive valuations versus US high yield and could benefit from the Fed beginning to tighten.
We find securitized credit attractive relative to investment-grade corporates from a valuation and risk perspective, given the abundance of asset types. We continue to favor US residential housing, where millennials should be a growing tailwind for demand. Securitized credit also offers floating-rate structures, which are appealing from a duration perspective. The updated risk factors adopted by the National Association of Insurance Commissioners are likely to increase demand for AAA and AA rated bonds.
Our base case is that central banks have clearly communicated their intentions to taper slowly, but a policy mistake remains a risk given the amount of liquidity in the system and its importance to markets. Bumps could occur if the Fed or ECB are perceived to be too hawkish or if their plans don’t change quickly enough in the face of a new variant or other COVID surprise.
COVID remains the bogeyman. Its impact on consumer preferences (more saving/less spending) could last longer than expected. And with more than five billion people unvaccinated worldwide, the potential for new, more dangerous variants requires investors to stay nimble and monitor portfolio risks carefully.
In addition, China’s opaque system is difficult to analyze and government priorities aren’t easy to infer. Although not our base case, China’s renewed focus on socializing wealth via regulations could continue or even increase. China’s housing market and debt levels are also concerns, as highlighted by Evergrande’s recent turmoil.
On the upside, two major market drivers, the Delta variant and China’s regulatory approach, could both ease in the coming months. EMs could benefit if China’s policymakers temper their tightening of the property market, boost infrastructure spending, and loosen climate controls — moves that could be spurred by politics ahead of the National Congress in November 2022.
Markets may also be positively surprised by the patience of central banks and find themselves awash in liquidity for several more quarters to come. Interest rates may stay low for an extended period, despite the economic recovery, and risk assets could appreciate further.
Finally, our inflation concerns may be ameliorated by a pickup in productivity, something that many economic models predict and that could get a boost from government spending on traditional and technological infrastructure after many years of underinvestment.
Stick with European equities — Europe’s economy is likely to emerge from the Delta surge first and with higher vaccination rates than other regions, including the US. Politics also seem to be at a tipping point with Chancellor Merkel’s term ending and other German parties intent on loosening fiscal constraints. We believe asset allocators can find yield, quality, and cyclicality in Europe at more attractive valuations than in the US, and particularly in industrials and banks.
Get more selective in credit — Most spreads are rich, but we don’t see a catalyst for them widening much. We see the best risk/reward potential in sectors like bank loans, collateralized loan obligations (CLOs), and residential-housing-oriented structured credit. We think select EM sovereign and EM corporate debt opportunities also offer better upside potential from a spread perspective than US corporates and high yield.
Pursue inflation protection with commodities — Inflation may reach higher levels or be more persistent than many asset allocators expect. While value-oriented equities may provide some protection, commodities (excluding precious metals) have historically been the most inflation-sensitive asset class.
Maintain fixed income for diversification — While our views tilt toward an economic recovery, we think it is still prudent to consider an allocation to high-quality bonds in case of a sharp equity sell-off. A global fixed income universe gives investors more opportunity to add value. We think municipal bonds can play a strategic role for taxable investors, especially given the trend toward greater federal spending. Precious metals and option strategies may provide additional ways to supplement bond exposure.